CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: RAB2B (ImmuneEditome ID:84932)

1. Gene summary of enriched editing regions for RAB2B

check button Gene summary
Gene informationGene symbol

RAB2B

Gene ID

84932

GeneSynonyms-
GeneCytomap

14q11.2

GeneTypeprotein-coding
GeneDescriptionras-related protein Rab-2B|GTP-binding protein RAB2B|RAS family, member RAB2B
GeneModificationdate20230329
UniprotIDQ8WUD1;E9PE37;A0A3B3ITL1
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr14:21460293-21460934:-ENST00000622293.3ENSG00000129472.11RAB2BexonicAluSp,AluScchr14:21460293-21460934:-.alignment


Top

2. Tumor-specific enriched editing regions for RAB2B


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
chr14:21460293-21460934:-BRCAEER5.8483e-07image
ENSG00000129472.11,RAB2BBRCAEAG7.3046e-07image
ENSG00000129472.11,RAB2BCOADEAG2.0789e-02image
chr14:21460293-21460934:-HNSCEER2.9507e-03image
ENSG00000129472.11,RAB2BHNSCEAG2.9513e-03image
chr14:21460293-21460934:-KIRCEER6.9478e-04image
ENSG00000129472.11,RAB2BKIRCEAG8.7136e-04image
chr14:21460293-21460934:-PRADEER4.9304e-03image
ENSG00000129472.11,RAB2BPRADEAG5.5731e-03image
chr14:21460293-21460934:-THCAEER1.6365e-09image
ENSG00000129472.11,RAB2BTHCAEAG1.6257e-09image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
ENSG00000129472.11,RAB2BKIRCPathEAG4.6290e-021.8863e-020.1045image
chr14:21460293-21460934:-THCAPathEER6.9420e-061.5439e-050.1963image
ENSG00000129472.11,RAB2BTHCAPathEAG6.5892e-061.4789e-050.1967image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for RAB2B


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr14:21460293-21460934:-LGGEERENSG00000048649,RSF1-0.45439.1480e-233.7527e-26-0.4421imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;RNF219;SAFB2;SF3A3;SF3B4;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAT_cells_CD8GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
chr14:21460293-21460934:-LGGEERENSG00000083168,KAT6A-0.44824.2237e-224.0500e-24-0.4252imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;RNF219;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184KAT6AT_cells_CD8GSVA_HALLMARK_MITOTIC_SPINDLE
chr14:21460293-21460934:-LGGEERENSG00000100888,CHD8-0.44465.0548e-224.4241e-30-0.4723imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;RNF219;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184CHD8Macrophages_M1GSVA_HALLMARK_MITOTIC_SPINDLE
chr14:21460293-21460934:-LGGEERENSG00000171681,ATF7IP-0.42941.2973e-209.5523e-23-0.4133imageNACIN1;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;RNF219;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAT_cells_CD8GSVA_HALLMARK_MITOTIC_SPINDLE
chr14:21460293-21460934:-LGGEERENSG00000092201,SUPT16H-0.42862.3515e-204.8589e-22-0.4069imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;RNF219;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAMonocytesGSVA_HALLMARK_MITOTIC_SPINDLE
chr14:21460293-21460934:-LGGEERENSG00000147548,WHSC1L1-0.42852.5630e-203.6489e-23-0.4170imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAMacrophages_M1GSVA_HALLMARK_XENOBIOTIC_METABOLISM
chr14:21460293-21460934:-LGGEERENSG00000118058,KMT2A-0.43032.5800e-202.5591e-22-0.4094imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;RNF219;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NANeutrophilsGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
chr14:21460293-21460934:-LGGEERENSG00000114739,ACVR2B-0.42043.5026e-202.3848e-22-0.4097imageNAIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;RNF219;SAFB2;SF3A3;SF3B4;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAMacrophages_M1GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
chr14:21460293-21460934:-LGGEERENSG00000032219,ARID4A-0.42703.6239e-202.6050e-25-0.4352imageNACIN1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAT_cells_follicular_helperGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY
chr14:21460293-21460934:-LGGEERENSG00000171988,JMJD1C-0.41883.6363e-201.3609e-23-0.4207imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAMacrophages_M1GSVA_HALLMARK_MYOGENESIS

More results



Top

4. Enriched editing regions and immune related splicing for RAB2B


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr14:21460293-21460934:-
CESCEERIRENSG00000160218.8chr2144082787:44083302:44084121:440842630.23262.5633e-022.5385e-140.4589imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAT_cells_CD4_memory_activatedGSVA_HALLMARK_MITOTIC_SPINDLE
ENSG00000129472.11,RAB2B
CESCEAGIRENSG00000160218.8chr2144082787:44083302:44084121:440842630.23262.4404e-022.5388e-140.4589imageNACIN1;ADAR;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DKC1;EIF4A3;ELAVL1;ELAVL3;FAM120A;FBL;FKBP4;FMR1;FUS;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP4B;LIN28;LIN28A;LIN28B;LSM11;MBNL2;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;PUM2;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RC3H1;RTCB;SAFB2;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;ZC3H7B;ZFP36;ZNF184NAT_cells_CD4_memory_activatedGSVA_HALLMARK_MITOTIC_SPINDLE
chr14:21460293-21460934:-
GBMEERIRENSG00000213398.3chr1667939749:67940478:67940736:67940825-0.28968.7775e-032.5519e-06-0.4143imageNACIN1;AUH;BCCIP;BUD13;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28B;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM22;RNF219;SAFB2;SF3A3;SF3B4;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAMacrophages_M0GSVA_HALLMARK_PEROXISOME
ENSG00000129472.11,RAB2B
GBMEAGIRENSG00000077454.11chr7100574010:100574356:100575704:100575782-0.38861.4212e-036.9766e-08-0.4082imageNACIN1;ADAR;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DKC1;EIF4A3;ELAVL1;FAM120A;FBL;FKBP4;FMR1;FUS;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHSRP;LARP4B;LIN28;LIN28A;LIN28B;LSM11;MOV10;MSI2;NONO;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RC3H1;SAFB2;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;ZNF184NAMonocytesGSVA_HALLMARK_ALLOGRAFT_REJECTION
ENSG00000129472.11,RAB2B
GBMEAGIRENSG00000102302.7chrX54445453:54446414:54447310:544474480.40624.5886e-041.9235e-090.4498imageNACIN1;ADAR;BCCIP;BUD13;CELF2;CNBP;CSTF2T;DDX54;DGCR8;DHX9;DKC1;EIF4A3;ELAVL1;FBL;FMR1;FUS;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;LIN28;LIN28A;LIN28B;MOV10;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;SF3B4;SRSF1;SRSF3;SRSF7;TAF15;TARDBP;TIA1;TROVE2;U2AF1;U2AF2;UPF1;YTHDC1;ZNF184FGD1MonocytesGSVA_HALLMARK_BILE_ACID_METABOLISM
ENSG00000129472.11,RAB2B
GBMEAGIRENSG00000182196.9chr12122980927:122980987:122981128:122981205-0.31349.1679e-037.7108e-07-0.4034imageNACIN1;ADAR;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DKC1;EIF4A3;ELAVL1;FAM120A;FBL;FKBP4;FMR1;FUS;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHSRP;LARP4B;LIN28;LIN28B;LSM11;MOV10;MSI2;NONO;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RTCB;SAFB2;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;ZNF184NAMonocytesGSVA_HALLMARK_FATTY_ACID_METABOLISM
chr14:21460293-21460934:-
GBMEERIRENSG00000013374.11chr7151368734:151374243:151375847:151375943-0.30814.4070e-032.5432e-06-0.4081imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;RNF219;SAFB2;SF3A3;SF3B4;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NUB1MonocytesGSVA_HALLMARK_PEROXISOME
ENSG00000129472.11,RAB2B
GBMEAGIRENSG00000136305.7chr1424305095:24306523:24307370:24307515-0.35685.6637e-039.0799e-08-0.4037imageNAUH;BCCIP;BUD13;CSTF2T;EIF4A3;FAM120A;FUS;GTF2F1;HNRNPA1;HNRNPC;HNRNPK;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP3;LIN28B;MSI2;PCBP2;PRPF8;RBFOX2;SF3A3;SF3B4;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TIA1;TRA2A;U2AF1;UPF1CIDEBMonocytesGSVA_HALLMARK_ALLOGRAFT_REJECTION
ENSG00000129472.11,RAB2B
GBMEAGA3ENSG00000102710.15chr1337012191:37012297:37009311:37009809:37009311:370106550.38491.0261e-032.4703e-080.4220imageNACIN1;ADAR;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DKC1;EIF4A3;ELAVL1;ELAVL3;FAM120A;FBL;FMR1;FUS;FXR1;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP4B;LIN28;LIN28B;LSM11;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;PUM2;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;SAFB2;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;ZC3H7B;ZFP36;ZNF184NAMonocytesGSVA_HALLMARK_BILE_ACID_METABOLISM
chr14:21460293-21460934:-
GBMEERESENSG00000099331.9chr1917209585:17209709:17210332:17210380:17210714:17210848-0.43501.3341e-041.8756e-08-0.4240imageNACIN1;AIFM1;AUH;BCCIP;BUD13;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHSRP;LIN28;LIN28B;MSI2;NOP56;NOP58;NUMA1;PRPF8;RANGAP1;RBFOX2;RBM10;RBM22;RNF219;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TNRC6A;TRA2A;U2AF1;U2AF2;UPF1;XRN2;ZNF184NAMonocytesGSVA_HALLMARK_ALLOGRAFT_REJECTION

More results



Top

5. Enriched editing regions and immune infiltration for RAB2B


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr14:21460293-21460934:-ACCEERMacrophages_M23.1461e-030.3845image
ENSG00000129472.11,RAB2BACCEAGMacrophages_M23.1461e-030.3845image
chr14:21460293-21460934:-BLCAEERMacrophages_M13.2541e-060.2676image
ENSG00000129472.11,RAB2BBLCAEAGMacrophages_M13.2895e-060.2675image
chr14:21460293-21460934:-BRCAEERT_cells_regulatory_(Tregs)5.7976e-060.1425image
ENSG00000129472.11,RAB2BBRCAEAGT_cells_regulatory_(Tregs)3.6337e-060.1454image
chr14:21460293-21460934:-CESCEERMacrophages_M04.1847e-03-0.1777image
ENSG00000129472.11,RAB2BCESCEAGMacrophages_M04.1851e-03-0.1777image
ENSG00000129472.11,RAB2BCHOLEAGPlasma_cells2.0857e-030.5661image
ENSG00000129472.11,RAB2BCOADEAGT_cells_follicular_helper2.0837e-020.1557image
ENSG00000129472.11,RAB2BDLBCEAGEosinophils1.1275e-020.5184image
chr14:21460293-21460934:-GBMEERMacrophages_M01.8373e-05-0.3287image
ENSG00000129472.11,RAB2BGBMEAGMacrophages_M01.8217e-05-0.3288image
chr14:21460293-21460934:-HNSCEERMacrophages_M15.3775e-060.2184image
ENSG00000129472.11,RAB2BHNSCEAGMacrophages_M15.3756e-060.2184image
chr14:21460293-21460934:-KICHEERDendritic_cells_activated2.2609e-02-0.2892image
ENSG00000129472.11,RAB2BKICHEAGDendritic_cells_activated2.2609e-02-0.2892image
chr14:21460293-21460934:-KIRCEERMacrophages_M26.3653e-04-0.1780image
ENSG00000129472.11,RAB2BKIRCEAGMacrophages_M26.7896e-04-0.1771image
chr14:21460293-21460934:-LGGEERMacrophages_M11.3200e-020.1089image
ENSG00000129472.11,RAB2BLGGEAGMacrophages_M11.3371e-020.1087image
chr14:21460293-21460934:-LUADEERT_cells_CD84.4207e-030.1307image
ENSG00000129472.11,RAB2BLUADEAGT_cells_CD83.6139e-030.1334image
chr14:21460293-21460934:-LUSCEERT_cells_CD4_memory_activated1.5943e-050.1958image
ENSG00000129472.11,RAB2BLUSCEAGT_cells_CD4_memory_activated1.5943e-050.1958image
ENSG00000129472.11,RAB2BMESOEAGT_cells_follicular_helper1.2148e-020.3094image
chr14:21460293-21460934:-OVEERMacrophages_M15.3003e-040.2103image
ENSG00000129472.11,RAB2BOVEAGMacrophages_M11.7305e-030.1898image
chr14:21460293-21460934:-PAADEERDendritic_cells_resting2.1212e-020.1838image
ENSG00000129472.11,RAB2BPAADEAGDendritic_cells_resting2.1212e-020.1838image
chr14:21460293-21460934:-PCPGEERNK_cells_resting6.2668e-050.3046image
ENSG00000129472.11,RAB2BPCPGEAGNK_cells_resting6.2668e-050.3046image
chr14:21460293-21460934:-PRADEERB_cells_naive2.4292e-03-0.1415image
ENSG00000129472.11,RAB2BPRADEAGB_cells_naive2.6164e-03-0.1403image
chr14:21460293-21460934:-SKCMEERT_cells_CD82.1402e-070.2395image
ENSG00000129472.11,RAB2BSKCMEAGT_cells_CD82.1402e-070.2395image
chr14:21460293-21460934:-STADEEREosinophils2.1825e-02-0.1280image
ENSG00000129472.11,RAB2BSTADEAGT_cells_CD81.0988e-020.1413image
chr14:21460293-21460934:-TGCTEERNK_cells_resting8.5937e-03-0.2262image
ENSG00000129472.11,RAB2BTGCTEAGNK_cells_resting8.5937e-03-0.2262image
chr14:21460293-21460934:-THCAEERT_cells_regulatory_(Tregs)9.0388e-040.1510image
ENSG00000129472.11,RAB2BTHCAEAGT_cells_regulatory_(Tregs)8.8754e-040.1512image
chr14:21460293-21460934:-THYMEERT_cells_gamma_delta2.8206e-030.3447image
ENSG00000129472.11,RAB2BTHYMEAGT_cells_gamma_delta2.8206e-030.3447image
chr14:21460293-21460934:-UCECEERMacrophages_M22.9987e-02-0.1990image
ENSG00000129472.11,RAB2BUCECEAGMacrophages_M22.2976e-02-0.2075image


Top

6. Enriched editing regions and immune gene sets for RAB2B


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000129472.11,RAB2BACCGSVA_HALLMARK_COAGULATIONEAG2.3009e-030.3959image
chr14:21460293-21460934:-ACCGSVA_HALLMARK_COAGULATIONEER2.3009e-030.3959image
chr14:21460293-21460934:-BLCAGSVA_HALLMARK_INFLAMMATORY_RESPONSEEER3.7975e-060.2658image
ENSG00000129472.11,RAB2BBLCAGSVA_HALLMARK_INFLAMMATORY_RESPONSEEAG3.7928e-060.2658image
chr14:21460293-21460934:-BRCAGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER4.5167e-250.3181image
ENSG00000129472.11,RAB2BBRCAGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG3.1518e-260.3253image
ENSG00000129472.11,RAB2BCESCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.3708e-040.2270image
chr14:21460293-21460934:-CESCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER2.3699e-040.2270image
ENSG00000129472.11,RAB2BCHOLGSVA_HALLMARK_GLYCOLYSISEAG2.9010e-02-0.4204image
ENSG00000129472.11,RAB2BCOADGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG1.4288e-030.2137image
ENSG00000129472.11,RAB2BDLBCGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG2.2790e-030.6039image
chr14:21460293-21460934:-ESCAGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEER2.5781e-060.3630image
ENSG00000129472.11,RAB2BESCAGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEAG8.6834e-060.3446image
chr14:21460293-21460934:-GBMGSVA_HALLMARK_BILE_ACID_METABOLISMEER2.5918e-090.4453image
ENSG00000129472.11,RAB2BGBMGSVA_HALLMARK_BILE_ACID_METABOLISMEAG2.7165e-090.4448image
chr14:21460293-21460934:-HNSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.4331e-160.3858image
ENSG00000129472.11,RAB2BHNSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.4301e-160.3858image
ENSG00000129472.11,RAB2BKICHGSVA_HALLMARK_SPERMATOGENESISEAG1.0226e-03-0.4072image
chr14:21460293-21460934:-KICHGSVA_HALLMARK_SPERMATOGENESISEER1.0226e-03-0.4072image
chr14:21460293-21460934:-KIRCGSVA_HALLMARK_GLYCOLYSISEER2.9850e-080.2850image
ENSG00000129472.11,RAB2BKIRCGSVA_HALLMARK_GLYCOLYSISEAG2.0030e-080.2884image
ENSG00000129472.11,RAB2BKIRPGSVA_HALLMARK_UV_RESPONSE_DNEAG9.9490e-03-0.1661image
chr14:21460293-21460934:-KIRPGSVA_HALLMARK_UV_RESPONSE_DNEER1.0014e-02-0.1660image
ENSG00000129472.11,RAB2BLAMLGSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALINGEAG3.4364e-020.2369image
ENSG00000129472.11,RAB2BLGGGSVA_HALLMARK_MITOTIC_SPINDLEEAG1.9568e-15-0.3398image
chr14:21460293-21460934:-LGGGSVA_HALLMARK_MITOTIC_SPINDLEEER1.9550e-15-0.3398image
ENSG00000129472.11,RAB2BLIHCGSVA_HALLMARK_HEME_METABOLISMEAG1.8802e-02-0.2035image
ENSG00000129472.11,RAB2BLUADGSVA_HALLMARK_APOPTOSISEAG6.3673e-070.2264image
chr14:21460293-21460934:-LUADGSVA_HALLMARK_APOPTOSISEER1.0224e-060.2225image
chr14:21460293-21460934:-LUSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.1427e-120.3174image
ENSG00000129472.11,RAB2BLUSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.1427e-120.3174image
ENSG00000129472.11,RAB2BMESOGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG1.7619e-020.2936image
ENSG00000129472.11,RAB2BOVGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG2.6549e-060.2813image
chr14:21460293-21460934:-OVGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.7080e-060.2874image
ENSG00000129472.11,RAB2BPAADGSVA_HALLMARK_MITOTIC_SPINDLEEAG1.3658e-02-0.1965image
chr14:21460293-21460934:-PAADGSVA_HALLMARK_MITOTIC_SPINDLEEER1.3658e-02-0.1965image
chr14:21460293-21460934:-PCPGGSVA_HALLMARK_SPERMATOGENESISEER6.3748e-06-0.3413image
ENSG00000129472.11,RAB2BPCPGGSVA_HALLMARK_SPERMATOGENESISEAG6.3748e-06-0.3413image
chr14:21460293-21460934:-PRADGSVA_HALLMARK_PROTEIN_SECRETIONEER2.5704e-11-0.3053image
ENSG00000129472.11,RAB2BPRADGSVA_HALLMARK_PROTEIN_SECRETIONEAG4.7196e-11-0.3011image
ENSG00000129472.11,RAB2BREADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG4.3736e-020.2305image
chr14:21460293-21460934:-READGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER4.3736e-020.2305image
ENSG00000129472.11,RAB2BSARCGSVA_HALLMARK_SPERMATOGENESISEAG2.3871e-03-0.2076image
chr14:21460293-21460934:-SARCGSVA_HALLMARK_SPERMATOGENESISEER2.4070e-03-0.2074image
chr14:21460293-21460934:-SKCMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER2.3586e-070.2387image
ENSG00000129472.11,RAB2BSKCMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.3586e-070.2387image
chr14:21460293-21460934:-STADGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER7.7791e-070.2716image
ENSG00000129472.11,RAB2BSTADGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG2.8302e-070.2810image
chr14:21460293-21460934:-TGCTGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER7.0265e-050.3365image
ENSG00000129472.11,RAB2BTGCTGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG7.0265e-050.3365image
ENSG00000129472.11,RAB2BTHCAGSVA_HALLMARK_GLYCOLYSISEAG1.0354e-070.2399image
chr14:21460293-21460934:-THCAGSVA_HALLMARK_GLYCOLYSISEER1.0445e-070.2398image
chr14:21460293-21460934:-THYMGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEER2.6135e-040.4150image
ENSG00000129472.11,RAB2BTHYMGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEAG2.6135e-040.4150image
chr14:21460293-21460934:-UCECGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER9.2155e-030.2378image
ENSG00000129472.11,RAB2BUCECGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.3329e-020.2254image
chr14:21460293-21460934:-UCSGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER1.3465e-040.5284image
ENSG00000129472.11,RAB2BUCSGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG1.3465e-040.5284image
chr14:21460293-21460934:-UVMGSVA_HALLMARK_G2M_CHECKPOINTEER7.3153e-03-0.3179image
ENSG00000129472.11,RAB2BUVMGSVA_HALLMARK_G2M_CHECKPOINTEAG7.3153e-03-0.3179image


Top

7. Enriched editing regions and drugs for RAB2B


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
chr14:21460293-21460934:-ACCImatinibEER5.2753e-03-0.3648image
ENSG00000129472.11,RAB2BACCImatinibEAG5.2753e-03-0.3648image
chr14:21460293-21460934:-BLCACMKEER2.3964e-06-0.2711image
ENSG00000129472.11,RAB2BBLCACMKEAG2.3677e-06-0.2712image
ENSG00000129472.11,RAB2BBRCACCT007093EAG8.3191e-110.2029image
chr14:21460293-21460934:-BRCAA.770041EER3.0403e-10-0.1971image
ENSG00000129472.11,RAB2BCESCBMS.536924EAG8.6628e-08-0.3257image
chr14:21460293-21460934:-CESCBMS.536924EER8.6571e-08-0.3257image
ENSG00000129472.11,RAB2BCHOLLenalidomideEAG3.4043e-04-0.6383image
ENSG00000129472.11,RAB2BCOADAKT.inhibitor.VIIIEAG4.9626e-030.1888image
ENSG00000129472.11,RAB2BDLBCBMS.708163EAG4.1325e-03-0.5746image
chr14:21460293-21460934:-ESCAGDC.0449EER1.2906e-04-0.2999image
ENSG00000129472.11,RAB2BESCAAZ628EAG4.1357e-03-0.2262image
ENSG00000129472.11,RAB2BGBMBIBW2992EAG3.5837e-12-0.5099image
chr14:21460293-21460934:-GBMBIBW2992EER3.7103e-12-0.5096image
ENSG00000129472.11,RAB2BHNSCCGP.60474EAG3.0575e-09-0.2822image
chr14:21460293-21460934:-HNSCCGP.60474EER3.0616e-09-0.2822image
chr14:21460293-21460934:-KICHGNF.2EER1.0528e-03-0.4062image
ENSG00000129472.11,RAB2BKICHGNF.2EAG1.0528e-03-0.4062image
chr14:21460293-21460934:-KIRCCyclopamineEER3.4140e-05-0.2157image
ENSG00000129472.11,RAB2BKIRCCyclopamineEAG3.0225e-05-0.2171image
chr14:21460293-21460934:-KIRPKU.55933EER2.2916e-04-0.2357image
ENSG00000129472.11,RAB2BKIRPKU.55933EAG2.2941e-04-0.2357image
ENSG00000129472.11,RAB2BLGGBAY.61.3606EAG5.8754e-150.3342image
chr14:21460293-21460934:-LGGBAY.61.3606EER5.9062e-150.3342image
ENSG00000129472.11,RAB2BLIHCLenalidomideEAG1.3046e-020.2156image
ENSG00000129472.11,RAB2BLUADBMS.509744EAG6.5102e-07-0.2262image
chr14:21460293-21460934:-LUADBMS.509744EER1.1858e-06-0.2212image
ENSG00000129472.11,RAB2BLUSCCI.1040EAG5.2150e-08-0.2456image
chr14:21460293-21460934:-LUSCCI.1040EER5.2150e-08-0.2456image
chr14:21460293-21460934:-OVGW843682XEER5.2905e-06-0.2740image
ENSG00000129472.11,RAB2BOVGW843682XEAG1.9018e-06-0.2852image
ENSG00000129472.11,RAB2BPAADCamptothecinEAG5.0574e-03-0.2248image
chr14:21460293-21460934:-PAADCamptothecinEER5.0574e-03-0.2248image
ENSG00000129472.11,RAB2BPCPGLapatinibEAG2.4544e-04-0.2802image
chr14:21460293-21460934:-PCPGLapatinibEER2.4544e-04-0.2802image
ENSG00000129472.11,RAB2BPRADBryostatin.1EAG4.3965e-13-0.3298image
chr14:21460293-21460934:-PRADBryostatin.1EER7.4019e-13-0.3271image
chr14:21460293-21460934:-READBortezomibEER9.0712e-03-0.2955image
ENSG00000129472.11,RAB2BREADBortezomibEAG9.0712e-03-0.2955image
ENSG00000129472.11,RAB2BSARCBMS.536924EAG7.3742e-06-0.3024image
chr14:21460293-21460934:-SARCBMS.536924EER7.2493e-06-0.3026image
chr14:21460293-21460934:-SKCMBMS.536924EER2.3274e-06-0.2195image
ENSG00000129472.11,RAB2BSKCMBMS.536924EAG2.3274e-06-0.2195image
ENSG00000129472.11,RAB2BSTADBMS.509744EAG6.8517e-07-0.2721image
chr14:21460293-21460934:-STADBMS.509744EER7.5898e-07-0.2719image
chr14:21460293-21460934:-TGCTCGP.082996EER1.1464e-02-0.2178image
ENSG00000129472.11,RAB2BTGCTCGP.082996EAG1.1464e-02-0.2178image
chr14:21460293-21460934:-THCAEmbelinEER4.5735e-140.3352image
ENSG00000129472.11,RAB2BTHCAEmbelinEAG4.8413e-140.3349image
chr14:21460293-21460934:-THYMCI.1040EER1.0224e-04-0.4390image
ENSG00000129472.11,RAB2BTHYMCI.1040EAG1.0224e-04-0.4390image
chr14:21460293-21460934:-UCECErlotinibEER2.2007e-02-0.2098image
ENSG00000129472.11,RAB2BUCECErlotinibEAG1.2903e-02-0.2264image
ENSG00000129472.11,RAB2BUCSATRAEAG1.7591e-030.4442image
chr14:21460293-21460934:-UCSATRAEER1.7591e-030.4442image
ENSG00000129472.11,RAB2BUVMAG.014699EAG2.1050e-030.3615image
chr14:21460293-21460934:-UVMAG.014699EER2.1050e-030.3615image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType